Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126801 · ClinicalTrials.gov registry record · Phase 2
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01126801: Clinical Trial Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01126801 is a Phase 2 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126801, a Phase 2 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This protocol is a controlled study of estradiol therapy in early postmenopausal women with and without frequent hot flashes that will be used to determine whether hot flashes are an important intermediary in the generation of menopause-associated depression.
Interventions
- DRUG Estradiol
- OTHER Placebo control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-02 |
| Phase | Phase 2 |
Why NCT01126801 stopped before completion
NCT01126801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Estradiol is the first listed.
NCT01126801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01126801 about?
NCT01126801 is a clinical study titled "Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women". This protocol is a controlled study of estradiol therapy in early postmenopausal women with and without frequent hot flashes that will be used to determine whether hot flashes are an important intermediary in the generation of menopause-associated depression.
What is the current status of trial NCT01126801?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2010-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01126801?
The interventions under investigation include: Estradiol (DRUG), Placebo control (OTHER).
Who is sponsoring clinical trial NCT01126801?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01126801's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia